GeneDx Holdings (WGS) Total Liabilities (2020 - 2026)

GeneDx Holdings has disclosed Total Liabilities across 7 years of filings, most recently posting $252.2 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 33.41% year-over-year to $252.2 million; the TTM figure through Mar 2026 stood at $252.2 million (up 33.41% YoY), while the FY2025 annual figure was $215.5 million, up 23.77% from the prior year.
• Total Liabilities advanced to $252.2 million in Q1 2026, from $215.5 million in the prior quarter.
• Over the last five years, Total Liabilities for WGS reached as high as $296.0 million in Q2 2022 and fell as low as $163.0 million in Q3 2023.
• The 5-year median for Total Liabilities is $195.1 million (2024), against an average of $208.6 million.
• The widest YoY moves for Total Liabilities: up 42.92% in 2022, down 53.72% in 2022.
• A 5-year view of Total Liabilities shows it stood at $237.2 million in 2022, then dropped by 19.6% to $190.7 million in 2023, then declined by 8.71% to $174.1 million in 2024, then rose by 23.77% to $215.5 million in 2025, then rose by 17.0% to $252.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $252.2 million, $215.5 million, and $201.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.